Gregory F. Keenan
Executive Officer at Jasper Therapeutics.
Raised on Jasper Therapeutics filings
$132M
of $132M offered across 1 Form D filing
- Form D filings
- 1
- Teammates
- 9
- Last filing
- Aug 4, 2026
Company
Jasper Therapeutics
Biotech · Redwood City, CA
Antibody drugs for chronic hives and rare immune diseases
Antibody drugs for chronic hives and rare immune diseases
- Investors
- 40
Jasper Therapeutics filings
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Aug 4, 2026 | Equity | $132M/ $132M | Form D |
- EquityFiled Aug 4, 2026Form D$132M/ $132M
